Advisory Services Network’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Advisory Services Network’s Portfolio VCNX Stock Details VCNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-24	Closed	-$10K	–	3046
2020 Q4	$10K	Hold	24	–	–	﹤0.01%	2450
2020 Q3	$9K	Buy	+24	New	+$26.2K	﹤0.01%	2527

Other funds holding VCNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Advisory Services Network's VCNX Position: Q1 2021 in Review

Advisory Services Network sold out of Vaccinex, Inc. Common Stock (VCNX) in Q1 2021, closing a stake of 24 shares — an estimated $10K sold.

Advisory Services Network first reported a position in VCNX in Q3 2020 and held it in 2 quarters. The position peaked at $10K in Q4 2020. 26 funds tracked by Wall St. Rank hold VCNX as of Q1 2021.

Advisory Services Network reported no remaining Vaccinex, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Advisory Services Network sold 24 Vaccinex, Inc. Common Stock shares in Q1 2021, an estimated $10K.
Advisory Services Network first reported a position in Vaccinex, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
Advisory Services Network's Vaccinex, Inc. Common Stock position peaked at $10K in Q4 2020.
26 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q1 2021.

Based on Advisory Services Network's 13F filing for Q1 2021, filed 24 May 2021.